acecainide has been researched along with Tachyarrhythmia in 18 studies
Acecainide: A major metabolite of PROCAINAMIDE. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.
N-acetylprocainamide : A benzamide obtained via formal condensation of 4-acetamidobenzoic acid and 2-(diethylamino)ethylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Antiarrhythmic properties of N-acetylprocainamide (NAPA), an active metabolite of procainamide, were studied in 12 patients with coronary artery disease who presented with cardiac arrest or documented sustained ventricular tachycardia (VT)." | 7.67 | Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. ( Flowers, D; Keefe, D; Miura, DS; Somberg, JC; Torres, V; Williams, S; Wynn, J, 1985) |
| "Antiarrhythmic properties of N-acetylprocainamide, an active metabolite of procainamide, were studied in 15 patients who presented with a cardiac arrest or documented sustained ventricular tachycardia." | 7.67 | N-acetylprocainamide's antiarrhythmic action in patients with ventricular tachycardia. ( Keefe, D; Miura, D; Somberg, J; Torres, V; Williams, S; Wynn, J, 1986) |
| "Twenty Caucasian adult patients with ventricular tachycardia were treated with intravenous procainamide." | 7.67 | Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations. ( Bauer, LA; Black, D; Gensler, A; Sprinkle, J, 1989) |
| "N-Acetylprocainamide (NAPA), a class III antiarrhythmic drug, caused torsade de pointes in a 72 year old woman who had this arrhythmia on two previous occasions while being treated with quinidine and disopyramide." | 3.67 | Torsade de pointes induced by N-acetylprocainamide. ( Asada, A; Atkinson, AJ; Bowsher, DJ; Chow, MJ; Kushner, W; Murphy, JJ; Piergies, AA; Ruo, TI; Talano, JV, 1984) |
| "Antiarrhythmic properties of N-acetylprocainamide (NAPA), an active metabolite of procainamide, were studied in 12 patients with coronary artery disease who presented with cardiac arrest or documented sustained ventricular tachycardia (VT)." | 3.67 | Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. ( Flowers, D; Keefe, D; Miura, DS; Somberg, JC; Torres, V; Williams, S; Wynn, J, 1985) |
| "Quinidine therapy is one of the most common causes of the acquired long QT syndrome and the morphologically distinctive tachyarrhythmia torsade de pointes." | 3.67 | Clinical features and basic mechanisms of quinidine-induced arrhythmias. ( Hoffman, BF; Roden, DM; Thompson, KA; Woosley, RL, 1986) |
| "Antiarrhythmic properties of N-acetylprocainamide, an active metabolite of procainamide, were studied in 15 patients who presented with a cardiac arrest or documented sustained ventricular tachycardia." | 3.67 | N-acetylprocainamide's antiarrhythmic action in patients with ventricular tachycardia. ( Keefe, D; Miura, D; Somberg, J; Torres, V; Williams, S; Wynn, J, 1986) |
| "Twenty Caucasian adult patients with ventricular tachycardia were treated with intravenous procainamide." | 3.67 | Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations. ( Bauer, LA; Black, D; Gensler, A; Sprinkle, J, 1989) |
| "Nineteen patients whose arrhythmias were initially suppressed with acetylprocainamide underwent long-term treatment with this drug." | 3.66 | Long-term antiarrhythmic therapy with acetylprocainamide. ( Drayer, DE; Kluger, J; Leech, S; Lloyd, V; Reidenberg, MM, 1981) |
| "A 66-year-old female with chronic renal failure received five doses of procainamide and developed marked QT interval prolongation and recurrent episodes of torsades de pointes, which were temporally related to high serum n-acetylprocainamide (NAPA) levels and not to procainamide levels." | 1.27 | Torsades de pointes due to n-acetylprocainamide. ( Stevenson, WG; Weiss, J, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kluger, J | 1 |
| Leech, S | 1 |
| Reidenberg, MM | 1 |
| Lloyd, V | 1 |
| Drayer, DE | 1 |
| Engel, TR | 1 |
| Olshansky, B | 1 |
| Martins, J | 1 |
| Hunt, S | 1 |
| Sung, RJ | 1 |
| Juma, Z | 1 |
| Saksena, S | 1 |
| Chow, MJ | 1 |
| Piergies, AA | 1 |
| Bowsher, DJ | 1 |
| Murphy, JJ | 1 |
| Kushner, W | 1 |
| Ruo, TI | 1 |
| Asada, A | 1 |
| Talano, JV | 1 |
| Atkinson, AJ | 1 |
| Marchlinski, FE | 1 |
| Buxton, AE | 1 |
| Vassallo, JA | 1 |
| Waxman, HL | 1 |
| Cassidy, DM | 1 |
| Doherty, JU | 1 |
| Josephson, ME | 1 |
| Stevenson, WG | 1 |
| Weiss, J | 1 |
| Wynn, J | 2 |
| Miura, DS | 1 |
| Torres, V | 2 |
| Flowers, D | 1 |
| Keefe, D | 2 |
| Williams, S | 2 |
| Somberg, JC | 1 |
| Nguyen, KP | 1 |
| Thomsen, G | 1 |
| Liem, B | 1 |
| Swerdlow, CD | 1 |
| Franz, MR | 1 |
| Roden, DM | 2 |
| Thompson, KA | 1 |
| Hoffman, BF | 1 |
| Woosley, RL | 2 |
| Borkan, SC | 1 |
| Morady, F | 1 |
| DiCarlo, LA | 1 |
| de Buitleir, M | 1 |
| Krol, RB | 1 |
| Baerman, JM | 1 |
| Kou, WH | 1 |
| Somberg, J | 1 |
| Miura, D | 1 |
| Fujii, T | 1 |
| Ohe, T | 1 |
| Deguchi, F | 1 |
| Shimomura, K | 1 |
| Ito, K | 1 |
| Bauer, LA | 1 |
| Black, D | 1 |
| Gensler, A | 1 |
| Sprinkle, J | 1 |
| Stratmann, HG | 1 |
| Walter, KE | 1 |
| Kennedy, HL | 1 |
| Herre, JM | 1 |
| Thompson, JA | 1 |
1 review available for acecainide and Tachyarrhythmia
| Article | Year |
|---|---|
The electropharmacology of acute drug testing using pacemakers.
Topics: Acecainide; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Dogs; Electrophysiology; Heart Co | 1982 |
17 other studies available for acecainide and Tachyarrhythmia
| Article | Year |
|---|---|
Long-term antiarrhythmic therapy with acetylprocainamide.
Topics: Acecainide; Acetylation; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arthritis, Rheum | 1981 |
N-acetyl procainamide causing torsades de pointes.
Topics: Acecainide; Aged; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Female; Hu | 1982 |
Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
Topics: Acecainide; Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiac Pacing, Artific | 1983 |
Torsade de pointes induced by N-acetylprocainamide.
Topics: Acecainide; Aged; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Kinetics; Procainamide; | 1984 |
Comparative electrophysiologic effects of intravenous and oral procainamide in patients with sustained ventricular arrhythmias.
Topics: Acecainide; Administration, Oral; Adult; Aged; Cardiac Pacing, Artificial; Electrophysiology; Female | 1984 |
Torsades de pointes due to n-acetylprocainamide.
Topics: Acecainide; Aged; Female; Humans; Kidney Failure, Chronic; Procainamide; Renal Dialysis; Tachycardia | 1985 |
Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
Topics: Acecainide; Aged; Coronary Disease; Electrocardiography; Electrophysiology; Female; Heart Arrest; He | 1985 |
N-acetylprocainamide, torsades de pointes, and hemodialysis.
Topics: Acecainide; Adult; Female; Glomerulonephritis; Humans; Procainamide; Renal Dialysis; Tachycardia | 1986 |
Clinical features and basic mechanisms of quinidine-induced arrhythmias.
Topics: Acecainide; Action Potentials; Animals; Bradycardia; Dogs; Dose-Response Relationship, Drug; Humans; | 1986 |
Hemoperfusion for N-acetylprocainamide intoxication.
Topics: Acecainide; Hemoperfusion; Humans; Procainamide; Tachycardia | 1986 |
Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia.
Topics: Acecainide; Aged; Cardiac Catheterization; Cardiac Pacing, Artificial; Dose-Response Relationship, D | 1986 |
N-acetylprocainamide's antiarrhythmic action in patients with ventricular tachycardia.
Topics: Acecainide; Drug Evaluation; Electric Stimulation; Heart Ventricles; Humans; Infusions, Intravenous; | 1986 |
[A case of torsade de pointes induced by N-acetyl procainamide].
Topics: Acecainide; Humans; Male; Middle Aged; Procainamide; Tachycardia | 1987 |
Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations.
Topics: Acecainide; Aged; Aging; Creatinine; Female; Heart Failure; Humans; Kidney; Kidney Diseases; Male; M | 1989 |
Torsade de pointes associated with elevated N-acetylprocainamide levels.
Topics: Acecainide; Humans; Male; Middle Aged; Procainamide; Tachycardia | 1985 |
QT prolongation and arrhythmia suppression.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Deafness; Death, Sudden; Elect | 1985 |
Polymorphic ventricular tachycardia and ventricular fibrillation due to N-acetyl procainamide.
Topics: Acecainide; Aged; Electrocardiography; Heart Ventricles; Humans; Male; Procainamide; Tachycardia; Ve | 1985 |